(Q68158839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Phase II trial of didemnin-B in advanced epithelial ovarian cancer. A Southwest Oncology Group study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

main subject

phase II clinical trial

1 reference

J M Cain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

P Y Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

D E Alberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

H H Gallion

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

L Laufman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

J O'Sullivan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

G Weiss

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

J N Bickers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 April 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

23-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

Antitumor activity of didemnin B in the human tumor stem cell assay

22 September 2019

cites work

1 reference

12 December 2020

New anticancer agents

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

1 reference

12 December 2020

Didemnins: Antiviral and Antitumor Depsipeptides from a Caribbean Tunicate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01275473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1607250%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference